Oorsprong van het eerstegraads netwerk van Nina Waibel
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 13 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Nina Waibel via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Sales & Marketing | |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Third Rock Ventures LP
Third Rock Ventures LP Investment ManagersFinance Third Rock Ventures LP seeks investment opportunities in life science companies located in the United States. The fund targets companies operating in the fields of sciences primarily in biotechnology, biopharmaceutical and medical devices. It provides financing for early stage capital requirements with an initial investment size of up to $30 million. It also acts as a lead investor. | Investment Managers | Corporate Officer/Principal | |
EpicentRx, Inc.
EpicentRx, Inc. Pharmaceuticals: MajorHealth Technology EpicentRx, Inc. develops compounds sourced and adapted from the aerospace industry for treating cancer. Its technology includes chemical platform, RRx-001 overview, rons potential, epigenetics, collaboration and immunotherapy. The company was founded by Susan J. Knox and Mark Bednarski and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Public Communications Contact | |
TYME TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Dartmouth College | College/University | Undergraduate Degree | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Dunbar Capital Management LLC
Dunbar Capital Management LLC Investment ManagersFinance Part of Dunbar Capital Investors LLC, Dunbar Capital Management LLC is a company based in Whippany, NJ. | Investment Managers | Corporate Officer/Principal | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal | |
Carson Group, Inc. (New York)
Carson Group, Inc. (New York) Investment ManagersFinance Carson Group provides financial information services. The firm specializes in global shareholder research and related advisory services. The company was foundedd by David M. Geliebter and is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
Rutgers State University of New Jersey | College/University | Masters Business Admin | |
Vassar College | College/University | Undergraduate Degree | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
The Rockefeller University | College/University | Doctorate Degree | |
University of Basel | College/University | Corporate Officer/Principal | |
University of Geneva | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | Miscellaneous Commercial Services | Director/Board Member | |
Fondation Mérieux | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Weill Cornell Medical College | College/University | Doctorate Degree | |
Institut Gustave Roussy EURL
Institut Gustave Roussy EURL Miscellaneous Commercial ServicesCommercial Services Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Natural Resources & Life Sciences | College/University | Doctorate Degree | |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Founder Director/Board Member | |
ACTINIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
NASDAQ
NASDAQ Investment Banks/BrokersFinance Part of Nasdaq, Inc., NASDAQ is a stock exchange. | Investment Banks/Brokers | Corporate Officer/Principal | |
University of Zurich Medical School | College/University | Undergraduate Degree | |
Saint Louis University School of Medicine | College/University | Doctorate Degree | |
ESCP Europe | College/University | Graduate Degree | |
GRITSTONE BIO, INC. | Biotechnology | Founder | |
Austrian Academy of Sciences
Austrian Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Austrian Academy of Sciences provides humanities and social science research services. The private company is based in Vienna, Austria. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Shire Austria GmbH
Shire Austria GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Austria GmbH develops and manufactures pharmaceutical products. The company is based in Donau, Austria. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Takeda Manufacturing Austria AG
Takeda Manufacturing Austria AG Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Manufacturing Austria AG manufactures and supplies vital medicines and medical devices. The company is based in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
Breath Therapeutics GmbH
Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breath Therapeutics GmbH is a clinical stage biopharmaceutical company, which engages in the development of inhaled therapeutics for respiratory diseases. It offers drug device platform, which consists of liposomal drug-aerosol formulations and cutting-edge inhalation technology. The company was founded by Jens Stegemann, Gerhard Boerner, Oliver Denk, and Anne Burger in 2016 and is headquartered in Munchen, Germany. | Pharmaceuticals: Major | Director/Board Member | |
TuHURA Biopharma, Inc.
TuHURA Biopharma, Inc. BiotechnologyHealth Technology TuHURA Biopharma, Inc. operates as a biotechnology company. It develops bifunctional immunoconjugates for the treatment of cancer. The company was founded in 2018 and is headquartered in Seattle,WA. | Biotechnology | Director/Board Member | |
Bill & Melinda Gates Medical Research Institute
Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Medical Research Institute is a non-profit organization that focuses on reducing the burden of tuberculosis, malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs). The private company is based in Cambridge, MA. The company works through collaborating partners and organizations to develop and effectively use novel biomedical interventions to address substantial health concerns. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Boehringer AG
Boehringer AG Pharmaceuticals: MajorHealth Technology Boehringer AG is an investment holding German company that owns subsidiaries which manufacture pharmaceutical products. The private company is based in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services The Society for Immunotherapy of Cancer (SITC) is an organization that advances the science, development, and application of immunotherapy to improve cancer patient outcomes. The non-profit company is based in Milwaukee, WI. SITC conducts policy and advocacy efforts on behalf of its members and the field. The Journal for Immunotherapy of Cancer (JITC) is the official open access, peer-reviewed online journal of SITC, featuring original research articles, literature reviews, position papers, and discussions on all aspects of tumor immunology and cancer immunotherapy. SITC also created a conceptual framework for potential value in phase III studies evaluating immunotherapy combinations. | Miscellaneous Commercial Services | Director/Board Member | |
Université Paris-Saclay | College/University | Corporate Officer/Principal | |
Mablink Bioscience
Mablink Bioscience Pharmaceuticals: MajorHealth Technology Mablink Bioscience is a biotechnology company based in Lyon, France that develops next-generation antibody-drug conjugates for the treatment of solid tumors. Mablink Bioscience's exclusive PSarlink™ platform is a unique stealth technology that "masks" the hydrophobicity of the cytotoxic drugs by adding a polysarcosine chain to the linker. The French company's pipeline is built on the topoisomerase-I inhibitor exatecan as a payload for current developments. Recently, the company announced the publication of a review article titled “Payload Diversification\: A Key Step in the Development of Antibody–Drug Conjugates” which reviews the history of the successes and failures in ADC payloads and takes a look at the new roads currently explored by the industry. The company was founded in 2018 by Warren Viricel and Jean-Guillaume Lafay, with Jean-Guillaume Lafay serving as CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
Cd Baker Consulting LLC | Corporate Officer/Principal | ||
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer. | Biotechnology | Director/Board Member | |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor |
Statistieken
Internationaal
Verenigde Staten | 30 |
Oostenrijk | 7 |
Frankrijk | 6 |
Duitsland | 5 |
Zwitserland | 5 |
Sectoraal
Health Technology | 23 |
Consumer Services | 13 |
Finance | 9 |
Commercial Services | 7 |
Miscellaneous | 2 |
Operationeel
Director/Board Member | 53 |
Corporate Officer/Principal | 39 |
Independent Dir/Board Member | 11 |
Chief Tech/Sci/R&D Officer | 11 |
Founder | 8 |
Sterkste connecties
- Beurs
- Insiders
- Nina Waibel
- Bedrijfsconnecties